Pharmaceutical Industry Revenues Could Decline Dramatically in 15 Years in
the Face of Price Controls, Access Restrictions and Patent Erosion
n
Product Revenues,
(Based on Fair Value and
Patent Protection)
n
Commercialization and
Market Competition
n
Funds Available
for Next Generation
Research
n
Reinvestment in New
Areas of Discovery
n
Potential
Molecule
Identified
n
Clinical Trials
n
Regulatory
Approval
Without a Fair Return,
The Model Breaks Down
Pharmaceutical
Industry